![]() |
Volumn 21, Issue 5, 2004, Pages 426-432
|
INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINE;
ADENOSINE DIPHOSPHATE RIBOSE;
ENZYME INHIBITOR;
FREE RADICAL;
INDOLE DERIVATIVE;
INO 1001;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
NITROPRUSSIDE SODIUM;
OXYGEN;
POLY(ADENOSINE DIPHOSPHATE RIBOSE);
ANIMAL;
ARTICLE;
BIOSYNTHESIS;
BLOOD FLOW;
DISEASE MODEL;
DOG;
DRUG ANTAGONISM;
HEART;
HEART ARREST;
HEART MUSCLE;
IMMUNOHISTOCHEMISTRY;
INFLAMMATION;
LUNG;
METABOLISM;
MUSCLE CONTRACTION;
PATHOLOGY;
PHYSIOLOGY;
REPERFUSION INJURY;
TIME;
ACETYLCHOLINE;
ADENOSINE DIPHOSPHATE RIBOSE;
ANIMALS;
DISEASE MODELS, ANIMAL;
DOGS;
ENZYME INHIBITORS;
FREE RADICALS;
HEART;
HEART ARREST;
HEART ARREST, INDUCED;
IMMUNOHISTOCHEMISTRY;
INDOLES;
INFLAMMATION;
LUNG;
MUSCLE CONTRACTION;
MYOCARDIAL REPERFUSION INJURY;
MYOCARDIUM;
NITROPRUSSIDE;
OXYGEN;
POLY ADENOSINE DIPHOSPHATE RIBOSE;
POLY(ADP-RIBOSE) POLYMERASES;
REGIONAL BLOOD FLOW;
REPERFUSION INJURY;
TIME FACTORS;
MLCS;
MLOWN;
|
EID: 5444223704
PISSN: 10732322
EISSN: None
Source Type: Journal
DOI: 10.1097/00024382-200405000-00005 Document Type: Article |
Times cited : (44)
|
References (0)
|